Testimony and Correspondence
Through its committees on Practice, Government Affairs, and Scientific Affairs, ASH formulates positions on pending federal legislation, regulations, and private insurance developments, which are communicated through congressional testimony and formal correspondence. In addition, ASH may submit comments to other organizations and governing bodies on issues related to research, practice, training, or quality of care issues affecting hematologists and their patients.
ASH Submits Comments to the US House of Representatives on the 21st Century Cures 2.0 Concept Paper
ASH Signs onto Letter Led by the Cogitative Care Alliance on the Physician Fee Schedule Proposed Rule
ASH Signs onto Letter to the FDA Led by Council of Medical Specialty Societies
ASH Signs on to AMA Letter on Surprise Billing in the COVID-19 Relief Legislation